(Reuters) – Levi Strauss’ shares slumped about 11% in premarket trading on Thursday after it forecast tepid holiday quarter revenue as the denim maker grapples with weak demand from retailers with consumers paring back spending. The company, whose stock has risen about 27% so far this year and was trading at $18.77 premarket, also said…
By Trevor Hunnicutt and Gabriella Borter (Reuters) – Vice President Kamala Harris plans to campaign with former Congresswoman Liz Cheney on Thursday in Wisconsin as the Democratic presidential candidate tries to court Republican and centrist voters in a battleground state for the Nov. 5 election. Cheney and her father Dick Cheney, former Vice President under…
By Lisa Richwine LOS ANGELES (Reuters) – One of two California doctors who were among the five people charged in the overdose death of “Friends” star Matthew Perry is expected to plead guilty on Wednesday to a charge of illegally distributing the drug ketamine. Dr. Mark Chavez has signed an agreement with prosecutors to plead…
By Akash Sriram (Reuters) -Tesla handed over fewer vehicles than analysts expected in the third quarter as stiff competition in China and Europe hit demand for its aging models, putting the electric-vehicle maker at risk of its first-ever decline in annual deliveries. Shares of the world’s most valuable automaker fell more than 6% in morning…
(Reuters) -Humana said on Wednesday that a lower-performance rating for a widely used Medicare insurance plan hurt enrollments for 2025 and will potentially hit the health insurer’s revenue and bonus payments in 2026, sending shares down about 23% premarket. The company said it has about 1.6 million, or 25% of its total members, currently enrolled…
By Krystal Hu (Reuters) – OpenAI has raised $6.6 billion from investors at a post-money valuation of $157 billion, cementing the ChatGPT maker’s status as one of the most valuable private companies in the world,sources familiar with the matter said on Wednesday. The funding has attracted returning venture capital investors including Thrive Capital and Khosla…
(Reuters) -U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center in Indiana that will focus on developing new ways to manufacture its drugs and increasing production of experimental medicines used in clinical studies. Lilly and Danish rival Novo Nordisk are market leaders for a class of weight-loss…
By Trevor Hunnicutt and Jasper Ward WASHINGTON (Reuters) – U.S. President Joe Biden said on Wednesday that he does not support strikes on Iran’s nuclear sites in response to its missile attack against Israel. “We’ll be discussing with the Israelis what they’re going to do, but all seven of us (G7 nations) agree that they…
(Reuters) – Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning…
By Howard Schneider NASHVILLE, Tennessee (Reuters) – The U.S. economy seems poised for a continued slowdown in inflation that will allow the Federal Reserve to cut its benchmark interest rate and “over time” reach a level that is no longer holding back activity, Fed Chair Jerome Powell said on Monday in remarks that showed no…
